This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Randomized Controlled Trial  • Psoriasis  • Dermatology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 2001;137:1637-1638.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A Double-blind, Randomized, Controlled Clinical Trial to Assess the Efficacy of a New Coal Tar Preparation (Exorex) in the Treatment of Chronic, Plaque-type Psoriasis
Smith CH, Jackson K, Chinn S, Angus K, Baker JNWN
Clin Exp Dermatol.
2000;4:25:580-583

Exorex (Malvern, Pa) is a new topical formulation for the treatment of psoriasis, containing 1% coal tar with the addition of synthetic esterified essential fatty acids, similar to those identified in banana skins. The Exorex product has been classified by the United Kingdom Medicines Control Agency in the general sales list category, and the product is also available in the United States. The product was launched in 1998 in England and received a great deal of interest from the press and the public because of the banana skin content (although this was synthetic). Exorex was perceived to be a safe and effective preparation, without the adverse effects and limitations of conventional medicines. . . . [Full Text of this Article]

Editor's Comment



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?